Crossmark Global Holdings’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-13,319
Closed -$369K 1336
2024
Q1
$369K Sell
13,319
-1,110
-8% -$24.6K 0.01% 1003
2023
Q4
$278K Buy
14,429
+361
+3% +$6.54K 0.01% 1100
2023
Q3
$228K Buy
+14,068
New +$250K 0.01% 1154
2022
Q3
Sell
-7,145
Closed -$225K 1266
2022
Q2
$225K Sell
7,145
-40
-0.6% -$1.45K 0.01% 1171
2022
Q1
$316K Buy
7,185
+120
+2% +$5.15K 0.01% 1115
2021
Q4
$307K Buy
+7,065
New +$277K 0.01% 1136
2021
Q3
Sell
-6,415
Closed -$272K 1422
2021
Q2
$272K Sell
6,415
-220
-3% -$8.56K 0.01% 1232
2021
Q1
$249K Buy
+6,635
New +$207K 0.01% 1266
2020
Q4
Sell
-21,295
Closed -$535K 1420
2020
Q3
$535K Sell
21,295
-1,370
-6% -$20K 0.02% 739
2020
Q2
$173K Sell
22,665
-1,110
-5% -$8.12K 0.01% 1262
2020
Q1
$218K Sell
23,775
-1,270
-5% -$7.67K 0.01% 1011
2019
Q4
$129K Sell
25,045
-1,510
-6% -$9.7K ﹤0.01% 1371
2019
Q3
$154K Sell
26,555
-210
-0.8% -$942 ﹤0.01% 1301
2019
Q2
$86K Sell
26,765
-85
-0.3% -$290 ﹤0.01% 1369
2019
Q1
$110K Sell
26,850
-10
-0% -$63 ﹤0.01% 1369
2018
Q4
$170K Sell
26,860
-3,480
-11% -$36.1K 0.01% 1326
2018
Q3
$501K Buy
30,340
+1,340
+5% +$22.8K 0.01% 950
2018
Q2
$485K Buy
29,000
+920
+3% +$14.9K 0.01% 968
2018
Q1
$437K Buy
28,080
+2,825
+11% +$50.4K 0.01% 1009
2017
Q4
$477K Buy
25,255
+12,395
+96% +$275K 0.01% 1033
2017
Q3
$376K Buy
+12,860
New +$380K 0.01% 1154
2016
Q3
$376K Buy
+12,860
New +$450K 0.01% 1154

Other funds holding ACH

Crossmark Global Holdings's ACH Position: Q2 2024 in Review

Crossmark Global Holdings sold out of Accendra Health (ACH) in Q2 2024, closing a stake of 13,319 shares — an estimated $369K sold.

Crossmark Global Holdings first reported a position in ACH in Q3 2016 and held it in 22 quarters. The position peaked at $535K in Q3 2020. 221 funds tracked by Wall St. Rank hold ACH as of Q2 2024.

  • Crossmark Global Holdings reported no remaining Accendra Health position as of Q2 2024 after selling out during the quarter.
  • Crossmark Global Holdings sold 13,319 Accendra Health shares in Q2 2024, an estimated $369K.
  • Crossmark Global Holdings first reported a position in Accendra Health in Q3 2016 and held it in 22 quarters.
  • Crossmark Global Holdings's Accendra Health position peaked at $535K in Q3 2020.
  • 221 funds tracked by Wall St. Rank held Accendra Health as of Q2 2024.

Based on Crossmark Global Holdings's 13F filing for Q2 2024, filed 29 Jul 2024.